BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35211029)

  • 1. Clinical Parameters and Metabolomic Biomarkers That Predict Inhospital Outcomes in Patients With ST-Segment Elevated Myocardial Infarctions.
    Liu J; Huang L; Shi X; Gu C; Xu H; Liu S
    Front Physiol; 2021; 12():820240. PubMed ID: 35211029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Plasma Metabolomics Identify 9-cis-retinoic Acid and Dehydrophytosphingosine Levels as Novel biomarkers for Early Ventricular Fibrillation after ST-elevated Myocardial Infarction.
    Luo J; Shaikh JA; Huang L; Zhang L; Iqbal S; Wang Y; Liu B; Zhou Q; Ajmal A; Rizvi M; Ajmal M; Liu Y
    Bioengineered; 2022 Feb; 13(2):3334-3350. PubMed ID: 35094641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk score to predict false-positive ST-segment elevation myocardial infarction in the emergency department: a retrospective analysis.
    Kim JH; Roh YH; Park YS; Park JM; Joung BY; Park IC; Chung SP; Kim MJ
    Scand J Trauma Resusc Emerg Med; 2017 Jun; 25(1):61. PubMed ID: 28666458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
    Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Plasma Metabolomics Implicates Modified 9-cis-Retinoic Acid in the Phenotype of Left Main Artery Lesions in Acute ST-Segment Elevated Myocardial Infarction.
    Huang L; Zhang L; Li T; Liu YW; Wang Y; Liu BJ
    Sci Rep; 2018 Aug; 8(1):12958. PubMed ID: 30154509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Metabolic Profile Determination in Young ST-segment Elevation Myocardial Infarction Patients with Ischemia and Reperfusion: Ultra-performance Liquid Chromatography and Mass Spectrometry for Pathway Analysis.
    Huang L; Li T; Liu YW; Zhang L; Dong ZH; Liu SY; Gao YT
    Chin Med J (Engl); 2016 May; 129(9):1078-86. PubMed ID: 27098794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a machine learning model to predict the risk of late cardiogenic shock in patients with ST-segment elevation myocardial infarction.
    Bai Z; Hu S; Wang Y; Deng W; Gu N; Zhao R; Zhang W; Ma Y; Wang Z; Liu Z; Shen C; Shi B
    Ann Transl Med; 2021 Jul; 9(14):1162. PubMed ID: 34430603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial.
    Cantor WJ; Goodman SG; Cannon CP; Murphy SA; Charlesworth A; Braunwauld E; Langer A
    Am Heart J; 2005 Feb; 149(2):275-83. PubMed ID: 15846265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting 30-day mortality after ST elevation myocardial infarction: Machine learning- based random forest and its external validation using two independent nationwide datasets.
    Hadanny A; Shouval R; Wu J; Shlomo N; Unger R; Zahger D; Matetzky S; Goldenberg I; Beigel R; Gale C; Iakobishvili Z
    J Cardiol; 2021 Nov; 78(5):439-446. PubMed ID: 34154875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of National Cardiovascular Data Registry risk models for mortality, bleeding and acute kidney injury in interventional cardiology at a German Heart Center.
    Wolff G; Lin Y; Quade J; Bader S; Kosejian L; Brockmeyer M; Karathanos A; Parco C; Krieger T; Heinen Y; Perings S; Albert A; Icks A; Kelm M; Schulze V
    Clin Res Cardiol; 2020 Feb; 109(2):235-245. PubMed ID: 31236693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACHTUNG-Rule: a new and improved model for prognostic assessment in myocardial infarction.
    Barra S; ProvidĂȘncia R; Paiva L; Caetano F; Almeida I; Gomes P; Marques AL
    Eur Heart J Acute Cardiovasc Care; 2012 Dec; 1(4):320-36. PubMed ID: 24062923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhang XT; Lin ZR; Zhang L; Zhao ZW; Chen LL
    BMC Cardiovasc Disord; 2022 Mar; 22(1):113. PubMed ID: 35300593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
    Nishiguchi T; Tanaka A; Taruya A; Emori H; Ozaki Y; Orii M; Shiono Y; Shimamura K; Kameyama T; Yamano T; Yamaguchi T; Matsuo Y; Ino Y; Kubo T; Hozumi T; Hayashi Y; Akasaka T
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2460-2467. PubMed ID: 27687605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention.
    Fu WX; Zhou TN; Wang XZ; Zhang L; Jing QM; Han YL
    Chin Med J (Engl); 2018 Jun; 131(12):1420-1429. PubMed ID: 29893358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Risk Stratification Score for Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Koowattanatianchai S; Chantadansuwan T; Kaladee A; Phinyo P; Patumanond J
    Cardiol Res; 2019 Dec; 10(6):350-357. PubMed ID: 31803333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of myocardial work in evaluating coronary microcirculation of STEMI patients after percutaneous coronary intervention.
    Ruizhong L; Yanhong L; Fei W; Yushi W; Yuqiong L
    Echocardiography; 2021 Dec; 38(12):2060-2068. PubMed ID: 34841596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of Plasma Myeloperoxidase and Trimethylamine N-Oxide to the GRACE Score Improves Prediction of Near-Term Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction.
    Tan Y; Zhou J; Yang S; Li J; Zhao H; Song L; Yan H
    Front Pharmacol; 2021; 12():632075. PubMed ID: 34650427
    [No Abstract]   [Full Text] [Related]  

  • 18. The Value of Pre-Infarction Angina and Plasma D-Dimer in Predicting No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients.
    Zhang H; Qiu B; Zhang Y; Cao Y; Zhang X; Wu Z; Wang S; Mei L
    Med Sci Monit; 2018 Jul; 24():4528-4535. PubMed ID: 29961077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction.
    Pan W; Sun M; Wu J; Dong H; Liu J; Gao R; Fang S; Xing L; Hu S; Yu B
    Atherosclerosis; 2020 Jun; 302():8-14. PubMed ID: 32387714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.
    Huang X; Redfors B; Chen S; Gersh BJ; Mehran R; Zhang Y; McAndrew T; Ben-Yehuda O; Mintz GS; Stone GW
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):172-180. PubMed ID: 30690854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.